Western blot analysis of GBM cells also showed an enhanced cleavage of initiator caspase-9, effector capase-3, and cleavage of PARP upon exposure to the combination treatment (Supplemental Figure 8C). This evidence concerns the gene CASP9 and glioblastoma.